Opus Genetics GAAP EPS of -$0.25 misses by $0.12, revenue of $3.08M in-line

* Opus Genetics press release [https://seekingalpha.com/pr/20303379-opus-genetics-announces-financial-results-for-third-quarter-2025-and-provides-corporate] (IRD [https://seekingalpha.com/symbol/IRD]): Q3 GAAP EPS of -$0.25 misses by $0.12.
* Revenue of $3.08M (-20.4% Y/Y) in-line.
* As of September 30, 2025, Opus Genetics had cash and cash equivalents of $30.8 million.

MORE ON OPUS GENETICS

* Opus Genetics, Inc. (IRD) Discusses OPGx-LCA5 Clinical Trial Data (Transcript) [https://seekingalpha.com/article/4826973-opus-genetics-inc-ird-discusses-opgx-lca5-clinical-trial-data-transcript]
* Opus Genetics, Inc. (IRD) OPGx-LCA5 Clinical Trial Data Presentation - Slideshow [https://seekingalpha.com/article/4826926-opus-genetics-inc-ird-special-call-slideshow]
* Opus Genetics, Inc. (IRD) Presents at H.C. Wainwright 27th Annual Global Investment Conference - Slideshow [https://seekingalpha.com/article/4821832-opus-genetics-inc-ird-presents-at-h-c-wainwright-27th-annual-global-investment-conference]
* Seeking Alpha’s Quant Rating on Opus Genetics [https://seekingalpha.com/symbol/IRD/ratings/quant-ratings]
* Historical earnings data for Opus Genetics [https://seekingalpha.com/symbol/IRD/earnings]